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PENILAIAN CORAK MEMPRESKRIPSI ANTIBIOTIK 01 HOSPITAL 
KERAJAAN 01 REPUBLIK YEMEN 
ABSTRAK 
Kajian penggunaan ubat adalah penting dalam menentukan status 
penggunaan ubat dalam sesuatu negara. Banyak kajian telah dijalankan untuk 
mendokumenkan corak penggunaan antibiotik dan ia menunjukkan bahawa 
mempreskripsi secara berlebihan, mempreskripsi drug berganda, salah guna ubat, 
penggunaan ubat-ubat mahal yang tidak perlu dan penggunaan antibiotik secara 
berlebihan merupakan masalah biasa penggunaan drug secara tidak rasional di 
kalangan pengamal perubatan. 
Kajian ini direkabentuk terutamanya bagi memfokus pada tingkahlaku 
pengamal perubatan tentang praktis mempreskripsi antibiotik di klinik pesakit luar di 
hospital kerajaan di Yemen. 
Kajian ini telah dihadkan kepada empat hospital kerajaan -- kemudahan 
penjagaan kesihatan kuartenari -· di Sana'a menggunakan kaedah penilaian semula 
penggunaan ubat secara prospektif. Kajian telah direkabentuk berdasarkan kaedah 
yang dijelaskan oleh Management Sciences for Health dan WHO. Persampelan 
preskripsi dilakukan mengikut kesenangan dan secara prospektif pada hari kajian dan 
di antara jam 10 pagi sehingga 1 petang. Sebanyak 300 preskripsi yang pertama 
diterima di kaunter farmasi bagi setiap hospital (sebanyak 1200 preskripsi dari 
kesemua hospital) dipilih secara bukan rawak. 
Keputusan menunjukkan bilangan total antibiotik berjenama yang 
dipreskripsikan adalah 76.8%. Lebih kurang 39.7% daripada drug dan 27.5% daripada 
antibiotik tidak mengikut Senarai Drug Perlu Negara Yemen. Daripada jumlah total, 
24.4% daripada antibiotik diprekripsikan tanpa dinyatakan kekuatan ubat, 30.1% tanpa 
dinyatakan des, 8.3% tanpa dinyatakan bentuk des, 31.8% tanpa dinyatakan 
kekerapan dan 67.9% tanpa dinyatakan jangkamasa. Kajian ini juga mengenalpasti 
xiii 
78.2% daripada pesakit yang menerima antibiotik telah memperolehi satu antibiotik 
manakala 21.8% menerima dua atau lebih antibiotik. Didapati 51.9% daripada 
preskripsi mengandungi antibiotik. Banyak daripada preskripsi yang mengandungi 
antibiotik tidak mengandungi maklumat mengenai diagnosis, nama, jantina dan umur 
pesakit. Purata bilangan ubat untuk setiap preskripsi adalah 2.6±1.3 (median = 3), 
peratus antibiotik daripada semua drug yang dipreskripsikan adalah 23.8% dan 
peratus drug berjenama yang dipreskripsikan daripada semua preskripsi adalah 
86.1 %, purata bilangan antibiotik untuk setiap pesakit yang menerima antibiotik adalah 
1.2±0.4 (median = 1 ), peratus drug dalam bentuk suntikan yang dipreskripsikan adalah 
31.8%, peratus antibiotik yang dipreskripsikan dalam bentuk suntikan adalah 27.8%, 
dan peratus vitamin/tonik yang dipreskripsikan bagi pesakit yang menerima antibiotik 
adalah 30.3%. Kos min preskripsi adalah US$8.60±7.50 (median = US$6.60) 
manakala kos min antibiotik bagi setiap pesakit yang menerima antibiotik adalah 
US$6.80±7.10 (median = US$4.60) dan peratus kos semua antibiotik daripada kos 
semua preskripsi adalah 40.2%. 
Corak tersebut menunjukkan kemungkinan terdapat berbagai masalah 
penggunaan drug dan antibiotik di hospital-hospital kerajaan kuartenari di Yemen. 
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EVALUATION OF ANTIBIOTICS PRESCRIBING PATTERN IN 
GOVERNMENT HOSPITALS OF YEMEN REPUBLIC 
ABSTRACT 
Drug utilization study is important in establishing the status of drug use in a 
particular country. Many studies have been carried out to document antibiotic use 
patterns, and indicate that over prescribing, multiple drug prescribing, misuse of drugs, 
use of unnecessary expensive drugs and overuse of antibiotics are the most common 
problems of irrational drug use by prescribers. 
The study was designed to focus mainly on the behaviour of the health care 
provider regarding antibiotic prescribing practice at outpatient clinics in public hospitals 
in Yemen. 
The scope of the study was limited to four public hospitals-- public quaternary 
health care facilities-- in Sana'a using the prospective drug utilization review method. 
The study was designed using the methods described by the Management Sciences 
for Health and WHO. Sampling of prescriptions was done prospectively on the days of 
survey and between 10 AM to 1 PM, with the first 300 prescriptions in each hospital 
(1200 prescriptions from all hospitals) i.e. convenient sampling. 
Results showed that the total numbers of brand name antibiotics prescribed 
were 76.8%. About 39.7% of the drugs and 27.5% of the antibiotics did not follow the 
Yemen Essential Drug List. Of the total, 24.4% of the antibiotics had unwritten strength, 
30.1% had unwritten dose, 8.3% had unwritten dosage form, 31.8% had unwritten 
frequency and 67.9% had unwritten duration. Out of the total number of patients who 
received antibiotics, 78.2% of them had received one antibiotic, while 21.8% had 
received 2 or more antibiotics. It was found that 51.9% of prescriptions contained 
antibiotics. These prescriptions with antibiotics were lack of important information-
diagnoses, patient's name, gender, and age. The average number of drugs per 
prescription was 2.6±1.3 (median = 3), the percentage of antibiotics from all drugs 
XV 
prescribed was 23.8%, the percentage of branded drugs prescribed in all prescriptions 
was 86.1 %, the average number of antibiotics per each patient received antibiotics was 
1.2±0.4 (median = 1 ), the percentage of antibiotics prescribed as injections was 27 .8%, 
and the percentage of vitamins/tonics prescribed for the patients received antibiotics 
was 30.3%. The mean cost of prescription was US$8.60±7.50 (median = US$6.60) 
while the mean cost of antibiotic per patient received antibiotic was US$6.80±7.10 
(median = US$4.60) and the percentage of all antibiotics cost from the cost of all 
prescriptions was 40.2%. 
The pattern on prescribing showed that there were possibilities of various 
potential drugs and antibiotics use problems in the government quaternary hospitals in 
Yemen. 
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1.0 Introduction 
CHAPTER 1 
INTRODUCTION 
In Yemen as well as in many other developing countries the quality of health 
services which constitute social indicators of justice and equity is far from being 
satisfactory. Inappropriate, ineffective, and inefficient use of drugs commonly occurs at 
different health facilities (Abdo-Rabbo, 1993; Abdo-Rabbo, 1997). Irrational prescribing 
is a habit, which is difficult to cure. This may lead to ineffective treatment, health risks, 
patient non-compliance, drug wastage, wasteful of resources and needless 
expenditure. According to the Yemeni constitution. "patients have the right to health 
care and treatment" i.e. appropriate care, consent to treatment and acceptable safety. 
Therefore, health workers should concentrate on making patients better and patients 
should concentrate on geting better. 
Health care in general and particularly the drug situation in any country is 
influenced by the availability, affordability, and access.ibility of drugs as well as the 
prescribing practices. There are many individuals or factors influence the irrational 
prescribing such as patients, prescribers, workplace environment, the supply system. 
including industry influences, government's regulations, drug information and 
misinformation (Geest S. V. et a/, 1991; Hogerzeil H. V., 1995). Improving rational use 
of drugs (RUD) is a very complex task worldwide because changing behavior is very 
difficult. Th'e 1985 Nairobi conference on the rational use of drugs marked the start of a 
global effort to promote rational prescribing (WH0,1987). In 1989, an overview of the 
subject concluded that very few interventions to promote rational drug use had been 
properly tested in developing countries (Laing et a/., 2001 ). 
The selection of drugs to satisfy the health needs of the population is an 
important component of a national drug policy. The selected drugs are called "essential 
drugs" which are the most needed for the health care of the majority of the population 
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in a given locality, and in a proper dosage forms. The national Jist of essential drugs 
(NEDL) is based on prevailing health conditions, drug efficacy, safety, and quality, cost-
effectiveness and allocated financial resources. 
WHO's mission in essential drugs and medicines policy is to help save lives and 
improve health by closing the huge gap between the potential that essential drugs have 
to offer and the reality that for millions of people particularly the poor and 
disadvantaged medicines are unavailable, unaffordable, unsafe or improperly used. 
The organization works to fulfill its mission in essential drugs and medicines policy by 
providing global guidance on essential drugs and medicines, and working with 
countries to implement national drug policies to ensure equity of access to essential 
drugs, drug quality and safety, and rational use of drugs. Development and 
implementation of national drug policies are carried out within the overall national 
health policy context, with care taken to ensure that their goals are consistent with 
broader health objectives. All these activities ultimately contribute to all four WHO 
strategic directions to: 
• reduce the excess mortality of poor and marginalized populations 
• reduce the leading risk factors to human health 
• develop sustainable health systems,and 
• develop an enabling policy and institutional environment for securing 
health gains. 
The greatest impact of WHO medicines activities is, and will continue to be, on 
reducing excess mortality and morbidity from diseases of poverty, and on developing 
sustainable health systems. 
"The people of our world do not need to bear the present burden of illness. Most 
of the severe illness that affects the health and well-being of the poorer people of our 
world could be prevented. But first, those at risk need to be able to access health care 
- including essential medicines, vaccines and technologies. Millions cannot - they 
cannot get the help they need, when they need it. As a result they suffer unnecessarily, 
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become poorer and may die young. A country's health service cannot respond to 
, people's needs unless it enables people to access essential drugs of assured quality. 
Indeed, this access represents a very important measure of the quality of the health 
service. It is one of the key indicators of equity and social justice." 
(Dr Gro Harlem Brundtland, Director-General, World Health Organization 
Opening remarks, Parliamentary Commission on Investigation of Medicines, Brasilia, 4 
April 2000). 
1.1 Background 
1.1.1 Brief. history of antibiotics 
According to the original definition by Waksman, antibiotics substances which 
are produced by microorganisms and which exhibit either an inhibitory or destructive 
effect on other microorganisms. In a wider, though not universally accepted definition; 
antibiotics are substances of biological origin, which without possessing enzyme 
character, in low concentrations inhibit cell growth processes (Rein~r. 1982). 
Up to now, more than 4,000 antibiotics have been isolated from microbial 
sources and reported in the literature, and more than 30000 semi-synthetic antibiotics 
have been prepared. Of these, only about 1 00 are used clinically as the therapeutic 
utility not only depends on a high antibiotic activity but also on other important 
properties such as good tolerance, favorable pharmacokinetics etc. These antibiotics 
are today among the most efficient weapons in the armoury of the physician in his fight 
against infectious diseases. They are therefore used a large extent and constitute the 
largest class of medicaments with respect to turnover value. Today, antibiotics are also 
used in veterinary medicine and as additives to animal feed. In the past they were used 
addition, as plant protection agents and as food preservatives. 
In this review we have confined ourselves to a brief description clinically useful 
antibiotics. These belong to various classes of chemical compounds, differ in !'rigin, 
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mechanism of action and spectrum activity, and are thus important and representative 
examples of known antibiotics. 
1.1.2 Problem Statement 
This study examines drug use in Yemen and factors leading to inappropriate 
use of medicines particularly antibiotics and the prescribing pattern. It defines rational 
drug use and describes policy developments, which aim to encourage appropriate use. 
In Yemen, as well as in many developing countries, the quality of health 
services is far from being achieved. Therefore, doctors should concentrate on making 
patients better and patients should concentrate on getting better. The rational use of 
drugs requires that patients received medications in appropriate to their clinical needs, 
in doses that meets their own requirements for an adequate period of time and at the 
lowest cost to them and their community (Bapna et at, 1994). This means deciding on 
the correct treatment for an individual patient based on good scientific reasons. It 
involves making an accurate diagnosis, selecting the most appropriate drug from these 
available, prescribing this drug in adequate doses for a sufficient length of time 
according to standard treatment. Furthermore, it involves monitoring the effect of the 
drug both on the patient and on the illness. 
There is plentiful evidence of the inappropriate use of drugs, not through self-
medication or unauthorized prescribing, but inadequate medical prescribing and 
dispensing. 
Normally, patients in Yemen enter health facilities with a set of symmetrical 
complaints, and with expectations about the care they typically receive; they typically 
leave with a package of drugs or with a prescription to obtain them in a private market. 
In previous study in Yemen (misuse of antibiotics in Yemen, a pilot study in Aden) 
(Abdo-Rabbo, 1997) showed that imported quantity and total consumption of antibiotics 
is increasing. There is a lack of information about the problems created from antibiotics 
among the community and about the proper efficacy, safety, and rational use of 
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antibiotics among health authority and workers. No supervision or strict rules are 
applied in the use of antibiotics. They are easily obtained without prescription and 
available in some shops. The percentage of prescriptions containing antibiotics was 
more than a quarter of the total prescriptions contained antibiotics, also antibiotics 
constituted about 25% of all prescribed drugs. 
1.1.2.1 Inappropriate Drug Use 
Increasing use of medicines may lead to an increase in the problems 
associated with medication use. The use of medicines, as well as improving health, can 
lead to undesirable medical, social, economic and environmental consequences. 
Aspects of drug use, which lead to such undesirable consequences, have been called 
inappropriate drug use (DHHCS, 1992; WHO, 1988). Inappropriate drug use may 
include under-use, over-use, over-supply, non-compliance, adverse drug reactions and 
accidental and therapeutic poisoning (DHHCS, 1992). It also includes medicating 
where there is no need for drug use, the use of newer, more expensive drugs when 
lower cost, equally effective drugs are available (WHO, 1988) and drug use for 
problems which are essentially social or personal (Frauenfelder and Bungey, 1985). 
1.1.2.2 Quality Use of Medicines 
In an attempt to encourage the appropriate use of medicinal drugs and to 
reduce the level of inappropriate use in Yemen, a policy was developed on the quality 
use of medicines. The stated aim of the policy is: "to optimise medicinal drug use (both 
prescription and OTC) to improve health outcomes for all Yemenis". The policy 
endorses the definition of quality drug use as stated by the World Health Organisation, 
"Drugs are often required for prevention, control and treatment of illness". When a drug 
is required, the rational use of drugs demands that the appropriate drug be prescribed, 
that it be available at the right time at a price people can afford, that it be dispensed 
correctly, and that it be taken in the right dose at the right intervals and for the right 
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length of time. The appropriate drug must be effective, and of acceptable quality and 
safety. The formulation and implementation by governments of a national drug policy 
are fundamental to ensure rational drug use (WHO, 1987; DHHCS, 1992). The rational 
use of drugs can be impeded by the inappropriate selection of management options, 
the inappropriate selection of a drug when a drug is required, the inappropriate dosage 
and duration of drug therapy and the inadequate review of drug therapy once it has 
been initiated. 
1.1.2.3 The Requirement of Drug Information for Quality Use of Medicines 
"A medicine has been described as an active substance plus information." 
(WHO, 1994). Education, together with, objective and appropriate drug information 
have been two of the factors consistently identified as necessary for rational drug use 
(Naismith, 1988; Soumerai, 1988; Carson et at, 1991; Dowden, 1991; Henry and 
Bochner, 1991; Tomson and Diwan, 1991 ). The WHO guidelines for developing 
national drug policies also identify the importance of information provision for facili!ating 
drug use: "Information on and promotion of drugs may greatly influence their supply 
and use. Monitoring and control of both activities are essential parts of any national 
drug policy" (WHO, 1988). Objective and appropriate drug information is a necessary 
factor for quality drug use. It is the basis for appropriate prescribing decisions by 
medical practitioners. Medical practitioners require objective product, specific drug 
information and comparative prescribing information. Objective drug information is 
available to medical practitioners through continuing education programs co-ordinated 
by professional bodies, medical and scientific journal articles, drug information services 
and drug formularies and guidelines. 
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1.1.2.4 Problem with antibiotic use 
The concerns regarding inappropriate antibiotic use can be divided into four 
areas: efficacy, toxicity, cost, and resistance. Inappropriate use of antibiotic can be due 
to:-
(i) Antibiotic use where no infection is present, e.g. continuation of peri-
operative prophylaxis for more than 24 hours after clean surgery. 
(ii) Infection, which is not amenable to antibiotic therapy, e.g. antibiotics 
prescribed for viral upper respiratory infection. 
(iii) The wrong drug for the causative organism, e.g. the use of broad 
anti-Gram negative agents for community acquired pneumonia. 
(iv) The wrong dose or duration of therapy. 
Such inappropriate use has a measurable effect on therapeutic efficacy. For 
example, one study showed that mortality in gram-negative septicemia is doubled 
when inappropriate empiric agents were used (Kreger eta/., 1980). Since most initial 
antibiotic therapy is empiric, any attempt at improving use must tackle prescribing 
habits, with particular emphasis on guidelines for therapy based on clinical criteria. 
Inappropriate antibiotic use exposes patients to the risk of drug toxicity, while 
giving little or no therapeutic advantage, antibiotics are often considered relatively safe 
drugs and yet direct and indirect side effects of their use are frequent and may be life-
threatening, allergic reactions, particularly to beta-lactam agents are well recognized 
and have been described in reaction to antibiotic residues in food (Barragry, 1994). 
Life threatening side effects may be occur from the use of antibiotics for 
apparently simple infections, it is estimated, for example, that eight people per year in 
UK die from side effects of co-trimoxazole usage in the community (Robert and 
Edmond, 1998). Indirect side effects are often overlooked: especially as may occur 
sometime after the antibiotic has been given. These include drug interactions (such as 
interference of antibiotic with anti-coagulant therapy and erythromycin with 
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antihistamine) (BNF, 1998), side effects associated with the administration of 
antibiotics (such as intravenous cannula infection) and super-infection (such as 
candidiasis and pseudomembranous colitis). Each of these may have a greater 
morbidity, and indeed mortality, than the initial infection for which the antibiotic was 
prescribed (Kunin eta/., 1993). 
The medical benefit of antibiotics does not come cheap. In the hospital setting, 
up to fifty percent of population receive one antibiotic during their hospital stay, with 
surgical prophylaxis accounting for thirty percent of this (Robert and Edmond, 1998). 
The first penicillin resistant isolate of Staphylococcus aureus was described 
only two years after the introduction of penicillin. Within a decade, 90% of isolates were 
penicillin resistant. This pattern of antibiotic discovery and introduction, followed by 
exuberant use and rapid emergence of resistance has subsequently been repeated 
with each new class of antibiotics introduced. Bacteria can so rapidly develop 
resistance due to two major evolutionary advantages. Firstly, bacteria have been in 
existence for some 3.8 billion years and resistance mechanisms have evolved over this 
time as a protective mechanism against naturally occurring compounds produced by 
other microorganisms. In addition, they have an extremely rapid generation time and 
can freely exchange genetic material encoding resistance, not only between other 
species but also between genera. The vast quantities of antibiotics used in both human 
and veterinary medicine, as a result present in the ·environment, have lead to 
emergence of infection due to virtually untreatable bacteria. Multiply drug resistant 
tuberculosis is already widespread in parts of Southern Europe and has recently 
caused outbreaks in hospitals in London (Hiramatsu eta/., 1997). 
Anti-infective are vital drugs, but they are over prescribed and overused in 
treatment of minor disorder such as simple diarrhea, coughs, and colds. When 
antibiotics are too often used in sub-optimal dosages, bacteria become resistant to 
them. The result is treatment failure where patient continue to suffer from serious 
infections despite taking the medication (Mohamed, 1999). 
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Drugs prescribed are in no way beneficial to the patient' s management if there 
are some negative interactions among the various agent prescribed, over prescribed, 
under prescribed or prescribed in the wrong dosage schedule. 
• How does one ensure that good drug are not badly used, misused, or even 
abused? 
• How can drugs be used rationally as intended? 
• What is rational use of drugs? What does rational mean? 
1.1.3 Rational Use of Drug 
"Rational use of drugs requires that patients receive medications appropriate to 
their clinical needs, in doses that meet their own individual requirements for an 
adequate period of time, and the lowest cost to them and their community" (Bapna et 
al., 1994). 
These requirements will be fulfilled if the process of prescribing is appropriately 
followed. This will include steps in defining patient's problems (or diagnosis); in defining 
effective and safe treatments (drugs and non-drugs); in selecting appropriate drugs, 
dosage, and duration; in writing a prescription; in giving patients adequate information; 
and in planning to evaluate treatment responses. The definition implies that rational 
use of drugs; especially rational prescribing should meet certain criteria as follows 
(Ross eta/., 1992): 
Appropriate indication. The decision to prescribe drug(s) is entirely based on 
medical rationale and that drug therapy is an effective and safe treatment. 
Appropriate drug. The selection of drugs is based on efficacy, safety, 
suitability, and considerations. 
Appropriate patient. No contraindications exist and the likelihood of adverse 
reactions is minimal, and the drug is acceptable to the patient. 
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Appropriate information. Patients should be provided with relevant, accurate, 
important, and clear information regarding his or her condition and the medication(s) 
that are prescribed. 
Appropriate monitoring. The anticipated and unexpected effects of 
medications should be: appropriately monitored (Vance and Millington, 1986). 
Unfortunately, in the real world, prescribing patterns do not always conform to 
these criteria and can be classified as inappropriate or irrational prescribing. Irrational 
prescribing may be regarded as "pathological" prescribing, where the above-
mentioned criteria are not fulfilled. Common patterns of irrational prescribing, may, 
therefore be manifested in the following forms: 
1. The use of drugs when no drug therapy is indicated, e.g., antibiotics for viral 
upper respiratory infections, 
2. The use of the wrong drug for a specific condition requiring drug therapy, e.g., 
tetracycline in childhood diarrhea requiring ORS, 
3. The use of drugs with doubtful/unproven efficacy, e.g., the use of antimotility 
agents in acute diarrhea, 
4. The use of drugs of uncertain safety status, e.g., use of dipyrone, 
5. Failure to provide available, safe, and effective drugs, e.g., failure to vaccinate 
against measles or tetanus, failure to prescribe ORS for acute diarrhea, 
6. The use of correct drugs with incorrect administration, dosages, and duration, 
e.g., the use of IV metronidazole when suppositories or oral formulations would 
be appropriate. 
7. The use of unnecessarily expensive drugs, e.g., the use of a third generation, 
broad spectrum antimicrobial when a first-line, narrow spectrum, agent is 
indicated. 
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Some examples of commonly encountered inappropriate prescribing practices 
in many health care settings include: (Avorn eta/., 1982). 
1. Overuse of antibiotics and antidiarrheals for non-specific childhood diarrhea, 
2. Multiple drug prescriptions, prescribe unnecessary drugs to counteract or 
augment, 
3. Drugs already prescribed, and 
4. Excessive use of antibiotics in treating minor respiratory tract infection. 
The drug use system is complex and varies from country to country. Drugs may 
be imported or manufactured locally. The drugs may be used in hospitals or health 
centers, by private practitioners and often in a pharmacy or drug shop where OTC 
preparations are sold. In some countries, all drugs are available over the counter. 
Another problem among the public includes a very wide range of people with 
differing knowledge, beliefs and attitudes about medicines. 
1.1.3.1 Factors Underlying Irrational Use of Drugs 
There are many different factors that affect the irrational use of drugs. In 
addition, different cultures view drugs in different ways, and this can affect the way 
drugs are used. The major forces can be categorized as those deriving from patients, 
prescribers, the workplace, the supply system including industry influences, regulation, 
drug information and misinformation, and combinations of these factors (Table 1.1) 
(Ross eta/., 1992). 
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Table 1.1: Factors affecting irrational use of drug 
1- Patients: drug misinformation Due to the misleading beliefs of patient and 
patient demands/expectations 
2- Prescribers: lack of education Due to inappropriate role models, lack of objective 
and training drug information, generalization of limited 
experience and misleading beliefs about drugs 
efficacy 
3- Workplace: heavy patient load Due to pressure to prescribe, lack of adequate Jab 
capacity and insufficient staffing 
4- Drug Supply System: unreliable Due to drug shortages and expired suppliers 
drugs supplied 
5- Drug Regulation: non-essential Due to non-formal prescribers and lack of 
drugs available regulation enforcement 
6- Industry: promotional activities Due to misleading claims 
Impact of Inappropriate Use of Drugs 
The impact of this irrational use of drugs can be seen in many ways: (Avorn et 
a/., 1982). 
1. Reduction in the quality of drug therapy leading to increased morbidity 
and mortality, 
2. Waste of resources leading to reduced availability of other vital drugs 
and increased costs, 
3. Increased risk of unwanted effects such as adverse drug reactions and 
the emergence of drug resistance, e.g., malaria or multiple drugs 
resistant tuberculosis, 
4. Psychosocial impacts, such as when patients come to believe that there 
is "a pill for every ill". This may cause an apparent increased demand for 
drugs. 
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1.1.3.2 The Rational Prescription (i.e. the right to prescribe) 
The rights to prescription writing must be ensuring the patient's five rights: the 
right drug, the right dose, by the right route, to the right patient, at the right time. 
Illegible handwriting and misinterpretation of prescriptions and medication orders are 
widely recognized causes of prescription error. The medicines should be prescribed 
only when they are necessary, should be written legibly in ink or, other wise, should be 
led, and should be signed in ink by the prescriber, The patients full name and address, 
diagnosis should be written clearly, the name of drugs and formulations should be 
written clearly and not abbreviated, using approved titles only. Dose and dose 
frequency should be stated; in the cases of formulations to be taken as required, a 
minimum dose should be specified (British National Formulary, 1998). 
1.2 Overview on Essential Drug Concept (EDC) 
Essential drugs relate to an international concept proposed by the World Health 
Organization (WHO) in 1977. WHO in that year published the first model list of 
essential drug and WHO has put in enormous resources into the campaign to promote 
the concept of essential drugs (EDL). Essential drugs were defined as a limited number 
of drugs that should be available at any time to the majority of population in appropriate . 
dosage forms and at affordable prices. In other words, it meets the criteria generally 
abbreviated as SANE [that mean safety, availability, need efficacy} (John, 1997). The 
essential drug concept is important in ensuring that the vast majority of the population 
is accessible to drugs of high quality, safety and efficacy relevant to their health care 
needs, and at reasonable cost (New Straits Times, 1997a). 
In support of this concept, the WHO issued a model drug list that provided 
examples of essential drugs. The list is drawn up by a group of experts based on 
clinical scientific merits, and provides an economical basis of drug use. This list is 
regularly, revised and, since 1997, eight editions have been published. This ensures 
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~ j that the need for essential drugs is always kept up-to-date with additions and deletions. 
Despite such rigorous revision, the number of drugs in the list remains at about 300, 
although the initial list comprised less. Most of the drugs are no longer protected by 
patents and can therefore be produced in quantity at a lower cost without comprising 
standards (WHO, 1995). This is indeed important for countries like Yemen not only 
because health care are rapidly escalating, but also because the country is still very 
dependent on imports of strategic commodities like drugs. The EDC will enable Yemen 
to focus on becoming self-reliant where generic equivalents of essential drugs can be 
manufactured and popularized to meet the health needs of the majority of the people. 
The limited number of drugs regarded as essential on the list offers a useful 
guide for practitioners as well as consumers. It underscores the general principle that a 
majority of diseases can be treated by similar drugs regardless of national boundaries 
and geographical locations (New Straits Times, 2000) Moreover, certain self-limiting 
diseases may not need "drug treatment" as such. For example, in the case of diarrhea, 
certain so-called potent anti-diarrhoeal drugs (including antibiotics) are not generally 
recommended. The more preferred treatment is oral rehydration salt that could easily 
be obtained or prepared at a fraction of the cost while giving the most optimum 
outcome. The goal of the Yemen Drug Policy was to: 
1) Prepare a list of essential drugs to meet the health of needs of the people. 
2) Assure that the essential drugs made available to the public are of good quality 
3) Improve prescribing and dispensing practices 
4) Promote rational use of drug by the public 
5) Lower cost of the drugs to the government and public 
6) Reduce foreign exchange expenditure 
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!JF 1.3 Yemen Essential Drug List and Drug Policy in Yemen 
The Concept of Essential Drugs (EDC) developed by World Health Organization 
(WHO) in 1977 has provided a rational basis, not only for drug procurement at national 
level but also for establishing drug requirements at various levels within the health care 
system. 
The WHO's Action Program on Essential Drugs (DAP) aimed to improve health 
care. It was established in order to provide operational support in the development of 
National Drug Policies (NDP), to improve the availability of essential drugs to the whole 
population and to work towards the rational use of drugs and consequently the patient 
care. The program seeks to ensure that all people, whenever they may be, are able to 
obtain the drugs they need at the lowest possible price: that these drugs are safe and 
effective; and that they are prescribed and used rationally. 
The first WHO Model List of Essential Drugs was published in 1977 (WHO, 
1977). Since that time essential drugs become an important part of health policies in 
developing countries: but the Essential Drugs Program has been criticized because it 
emphasis in improving supply of drugs rather than their rational prescribing. The recent 
revised WHO Model List of Essential Drugs was published the 131h edition in April 2003 
(WHO, 2003). Yemen was one of the first countries in the region adapted the EDC in 
1984 and implemented this concept in the public sector (Hogerzeil et a/., 1989). The 
first Yemen (National) Essential Drugs List (YEDL) was officially issued in 1987 based 
on the WHO List of Essential Drugs and other resources. The second edition of the 
Yemen Drugs list and the Yemen Standard Treatment Guidelines were published in 
1996 (MoPH&P/NEDL, (1996); MoPH&P/NSTG, (1996). Recently the latest edition was 
published in 2001 with the Standard Treatment Guidelines (STG) in the same booklet 
(MoPH&P/YSTG and YEDL, 2001 ). The new edition of the Treatment Guidelines and 
the Essential Drugs List has been created through a long process of consultation of 
medical and pharmaceutical professionals in Yemen and abroad. Review workshops 
were held in Sana'a and Aden and more than 200 representatives of the health 
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workers from different governorates including the major medical specialists 
participated. 
Essential drugs are selected to fulfil the real needs of the majority of the 
population in diagnostic, prophylactic, therapeutic and rehabilitative services using 
criteria of risk-benefit ratio, cost-effectiveness, quality, practical administration as well 
as patient compliance and acceptance (Budon-Jakobowiez, 1994). 
The YEDL was initially used for the rural health units and health centers as well 
as some public hospitals, but not applied for all levels of health care and the private 
sector. However, despite the recognition of the essential drug concept by the 
government of Yemen represented by the Ministry of Public Health and Population 
(MoPH&P), drugs remain in short supply to many of the population and irrationally 
used. Procurement cost is sometimes needlessly high. Knowledge of appropriate drug 
use and the adverse health consequences remain unacceptably low. In addition, 
diminished funding in the public sector resulted in shortage of pharmaceuticals. 
The 20th century has witnessed an explosion of pharmaceutical discovery, 
which has widened the therapeutic potential of medical practice. The vast increase in 
the number of pharmaceutical products marketed in the last decades has not made 
drug available to all people and neither has resulted in the expected health 
improvement. While some of the newly invented drugs are significant advance in 
therapy, the majorities of drugs marketed as "new" are minor variations of existing drug 
preparations and do not always represent a significant treatment improvement. In 
addition, the vast number "brand names" products for the same drug increases the 
total number of products of this particular drug resulting in an unjustified large range of 
drug preparations marketed throughout the world. 
The regular supply of drugs to treat the most common diseases was a major 
problem for governments in low-income countries. The WHO recommends that 
activities to strengthen the pharmaceutical sector be organized under the umbrella of 
the national drug policy (WHO, 1988). In 1995, over 50 of these countries has 
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formulated National Drug Policies (NDP). The NDP is a guide for action, containing the 
goals set by the government for the pharmaceutical sector and the main strategies and 
approaches for attaining them. It provides a framework to co-ordinate activities of 
patients involved in pharmaceutical sector, the public sector, the private sector, non-
governmental organizations (NGOs), donors and other interested parties. A NDP will 
therefore, indicate the various courses of action to be in relation to medicines within a 
country. 
The Yemen National Drug Policy was developed since 1993 with the objectives 
of ensuring availability of essential drugs through equitable distribution, ensuring drugs 
efficacy and safety, as well as promoting the rational use of drugs. Unfortunately, it has 
not been systemically implemented (Abdo-Rabbo, 2001 a). During the last years efforts 
have been increased to improve drug practices in the country. National and 
international programs as well as donor organizations established in the country 
concentrated mainly on improving the availability of essential drugs as well as 
promoting the rational use of drugs. The government should endeavour to make 
essential drugs of acceptable quality in sufficient quantities available to all who need 
them at lowest possible cost. Health Sector Reform (HSR) is a process aimed to 
improve equity, quality, and efficacy in the health sector through changes in the 
organization and financing of health services. One of the HSR components is the Drug 
Financing Reforms (DFR). The type of arrangement arranged by the government is the 
Revolving Drug Fund (RDF). In a RDF, a sum or money contributed by the 
government, donors, or the community is used to purchase an initial stock of drugs and 
ensure a continuous supply. The Drug Fund (OF) for Medical Supply which is recently 
established in Yemen aimed to increase availability of drugs, ensure more affordable 
drugs, make low-cost essential drugs more accessible, improve patient adherence to 
treatment, and increase price awareness by prescribers and patients, and improve 
rational use of drugs. 
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Normally patients enter health facilities with a set of symptoms and complaints, 
and with expectations about the care they will receive. They typically leave with a 
package of drugs or with a prescription to obtain them in a private market. WHO 
promotes the use of generic names of drugs. Most of the essential drugs are now no 
longer patent products and can in principle be manufactured under their International 
Non-proprietary Names (INN) or generic names. 
The adequacy of patient care is measured by different parameters. International 
health organizations interested in the subject particularly WHO Action Program on 
Essential Drugs (WHO/DAP), the International Network for Rational Use of Drugs 
(INRUD) and other organizations have made serious attempts to examine drug use 
rationality and developed indicators for assessment. The developed drug use indicators 
to measure the prescribing performance in health facilities were used in this study 
(WHO, 1993). 
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1.4 Treatment Guideline 
Some physicians inappropriately prescribe expensive antibiotics, which are 
countering productive to patient (e.g. fungal infection linked to overuse of 
cephalosporins (WHO, 1993a). WHO recommends research by educational institutions 
on the rational prescription of drug by physicians, which can become the basis of 
regulatory legislation (WHO, 1993a). Monitoring of the duration of antibiotic therapy 
poses a problem for evaluators since it varies on criteria that are more subjective than 
objective. Standard medical references allow one an enormous leeway in deciding the 
length of therapy for infections (Farber eta/., 1995). Even then prescription audit, drug 
utilization studies, reviewing drug expenditure trends and patterns are certainly of 
immense value in taming policy and initiating corrective measures for appropriate 
usage of antibiotics. 
Generally, drug utilization study is important in establishing the status of drug 
use in particular country; the goal of drug utilization review has been to increase the 
appropriateness of drug therapy by focusing on whether a drug is being effectively 
used [e.g., appropriate dose, duration of therapy, etc}. To influencing future prescribing 
and dispensing, drug utilization review criteria may also be applied retrospectively to 
pharmacy claims data to identify physicians and pharmacists who need education 
about appropriate drug use (Edward, 2000). 
Drug therapy is considered to be a major component of patient management in 
health care settings, including primary health care. The risks of drugs per use and the 
consequences of inappropriate use cannot be over looked. Additionally, the cost of 
medicine is a matter of great concern in both developing and industrialized countries. 
Among the various classes of drugs, antibiotics receive special attention as more 
money is spent on them other than many other drugs (Gugliemo and Brooks, 1989). 
Some antibiotics also have specific side effects and extensive antibiotic use lead to the 
development of resistant microorganisms (Farrar, 1985). 
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The guidelines emphasized the following: 
• The presence of up-to-date information about all antibiotics in each primary 
health care center and hospital. 
• Methods and strategies for choosing appropriate antibiotics for a specific 
disease condition. 
• The establishment of antibiotics subcommittees in each health care facility for 
auditing antibiotics use. The information package contained articles about the 
use and abuse of antibiotics. Worldwide meeting were organized with the 
physician of the district to discuss the states of antibiotics and the details of the 
guidelines. 
1.5 Why Antibiotics? 
The detection of problems with antimicrobial drug use in hospitals is the first 
step in evaluating the underlying causes and taking remedial action. The management 
and us~ of antimicrobial drugs has clinical, economic, and environmental implications. 
In many countries, antimicrobial drugs are the most frequently prescribed therapeutic 
agents, accounting for 30 to 50 percent of drug prescriptions. From a clinical 
standpoint, there are three principal concerns surrounding the use and management of 
antimicrobial drugs: 
1. They are necessary for treatment of most bacterial infections. If they are not 
available in hospital pharmacies, lives may be jeopardized. 
2. They may be prescribed inappropriately by physicians and drug sellers and 
especially by the general public (self-prescribing) where antimicrobial drugs are 
sold over the counter. Inappropriate prescribing includes use of antimicrobial 
drugs without proof of infection or to treat viral infections or non-infectious 
diarrhoea. The wrong drug may be prescribed or taken for a particular infection 
or, if the correct drug is used, it may be prescribed or taken at the _wrong 
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dosage or by an inappropriate route of administration. Perhaps the greatest 
misuse of antimicrobial drugs is shortened duration of therapy. 
3. Adverse drug reactions (ADRs) constitute the third critical area of antimicrobial 
drug use. Such reactions include nephrotoxicity and allergic reactions as well as 
antibiotic associated diarrhoea. It is estimated that 25 percent of ADRs are 
caused by antimicrobial drugs (Beringer et a/., 1998 ). 
In conclusion, hospitals must ensure availability of antimicrobial drugs while at 
the same time controlling and improving prescribing practices of physicians and 
minimizing untoward side effects. In economic terms, expenditures on antimicrobial 
drugs in the year 2000 are projected at $40 billion with about one-third of that in 
developing countries. Worldwide, antimicrobial drugs accounted for 12 percent of all 
pharmaceutical sales in 1990 while in developing countries they accounted for 19 
percent; this proportion was projected to increase to 34 percent in 2000 (Liss, RH, and 
FR Batchelor, 1987). Thus, antimicrobial drugs are a large and growing component of 
pharmaceutical expenditures in developing countries and must be managed effectively 
in the face of limited financial resources. 
Finally, cases of antimicrobial drug resistance have drawn public attention to 
the public health and ecologic implications of drug-resistant microorganisms in the 
environment. The very ubiquity of antimicrobial drugs and their frequent over- and 
under-use are associated with the appearance of antimicrobial drug-resistant strains of 
major pathogens such as Staphylococcus aureus and Pseudomonas spp. (Urassa et 
a/., 1997; Centres for Disease Control, 1997). Highest levels of resistance to 
antimicrobial drugs occur in countries with highest levels of antimicrobial drug use 
(WHO, 1984; Levy et a/., 1987; Kunin, 1993). It has been estimated that hospital-
acquired infections due to drug-resistant organisms cost the United States $4 billion in 
1990 (Institute of Medicine, 1998). The high cost of treating drug-resistant infections 
may exceed the financial capacity of many patients and hospitals in deveioping 
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countries. Thus, managers must monitor and minimize antibacterial resistance in their 
hospitals. 
1.5.1 How to Investigate Antimicrobial Drug Use in Hospitals? 
The Rational Pharmaceutical Management (RPM) Project of the U.S. Agency 
for International Development (USAID) has produced two drug assessment manuals 
based on indicators (Rapid Pharmaceutical Management Assessment: An Indicator-
Based Approach and Drug Management for Childhood Illness Manual). Both of these 
manuals were aimed at assessing outpatient drug use as opposed to hospital inpatient 
use and were directed at a broad range of pharmaceutical products, not specifically 
antimicrobial drugs (also referred to in this document as antimicrobials or AMOs). In 
1993, the World Health Organization (WHO) published "How to investigate drug use in 
health facilities": selected drug use indicators. Only 2 of the 19 indicators in that 
publication specifically referred to antibiotic use or management. 
In response to antimicrobial drug resistance legislation by the U.S. Congress, 
RPM proposed to USAID to development of a manual for assessment of antimicrobial 
drug use in hospitals. Such a manual would be a tool for hospital managers to assess 
antimicrobial drug management and use and thus contribute to reducing antibiotic 
misuse, a congressionally mandated objective for USAID worldwide. 
The present manual is intended for use by hospital drug and therapeutics 
committees (DTCs), physicians, pharmacists, and managers, as well as drug use 
researchers who wish to evaluate and improve antimicrobial drug use in hospitals. It 
will allow basic comparisons of antimicrobial drug use in a hospital over time and 
between hospitals (RPMPP, 2001 ). 
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1.5.2 Objectives of a Hospital Antimicrobial Use Study 
Hospital administrators, researchers, and DTCs will want to study antimicrobial 
drug use in order to: 
1. Describe antimicrobial drug prescribing practices 
2. Compare performance among hospitals or prescribers 
3. Monitor performance and orient supervision 
4. Assess changes resulting from interventions 
Once problems have been detected, investigators will decide whether further 
study is warranted to explore causes of the problems detected in the first round. 
These additional studies will explore areas such as: 
o Antimicrobial drug selection procedures and criteria 
o Antimicrobial use in specific wards or specialties or by individual 
prescribers 
o Purchasing and financing of drugs and antimicrobial drugs 
o Impediments to patient compliance with antimicrobial drug prescriptions. 
o Comparison of antimicrobial drug use among hospitals 
Investigators should clearly state why the study is needed and what is expected as the 
outcome. For example, hospital management may want to use the following wording: 
"Undertake a rapid, hospital- wide review of antimicrobial drug use and management to 
detect problem areas and assign responsibility for correction to the respective 
departments". 
1.5.3 Antibiotic prescribing and bacterial resistance 
Increasing bacterial resistance to antibiotics is becoming a significant issue, 
both in primary and secondary care. The Standing Medical Advisory Committee 
(SMAC) report 'The path of least resistance' points out that some 50 million 
prescriptions for antibiotics are dispensed each year in England alone; 80% of this 
activity occurs in primary care (SMAC, 1998). A twofold variation exists in levels of 
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antibiotic usage between the areas of highest and lowest prescribing, for which there is 
no apparent explanation. Although antibiotic resistance is a worldwide problem, there is 
evidence that local antibiotic prescribing practices can affect local resistance patterns. 
A study in Wales investigated antibiotic prescribing in general practitioners' surgeries 
and resistance to antibiotics over the period from March 1 996 to April 1 998. Rates of 
prescribing for urinary tract infections and resistance rates in coliform organisms were 
examined (Magee et at.. 1 999). A correlation between the rate of prescribing of an 
antibiotic and the rate of resistance to that agent was demonstrated. A cross-sectional 
survey in Iceland also found that carriage of penicillin resistant pneumococci was 
strongly associated with both individual and community-wide levels of antibiotic use 
(Arason et at., 1 996). In Finland, the incidence of erythromycin resistance in group A 
streptococcus reduced by half over three years following a campaign to reduce the use 
of macrolide antibiotics (Seppala et a/ .. 1997). 
1.5.4 Disadvantages of antibiotic prescribing 
Antibiotics are associated with several well-documented common side effects, 
including diarrhoea and rashes, as well as rare, but potentially life-threatening, 
anaphylactic reactions. The risk of side effects should always be considered before 
prescribing any medication. Prescribing antibiotics can also have other, perhaps 
unforeseen, consequences. In the open study comparing three approaches to the 
management of sore throat, patients who received an immediate prescription for 
antibiotics were more likely to believe that antibiotics were effective in this condition 
(Little eta/., 1997a). They were also more likely than other patients to intend consulting 
a GP in future episodes. In a follow-up study, a higher reconsultation rate in those 
patients who had been given immediate antibiotic treatment was demonstrated (Little et 
at., 1997). 
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